Precision Biosciences (DTIL) Net Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | -30.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.27% |
| Dec 31, 2025 | 612.76% |
| Sep 30, 2025 | -506.06% |
| Jun 30, 2025 | -5.55% |
| Mar 31, 2025 | -141.16% |
| Dec 31, 2024 | -131.59% |
| Sep 30, 2024 | 85.59% |
| Jun 30, 2024 | 30.20% |
| Mar 31, 2024 | 167.07% |
| Dec 31, 2023 | 75.29% |
| Sep 30, 2023 | -155.75% |
| Jun 30, 2023 | -129.95% |
| Mar 31, 2023 | -14.59% |
| Dec 31, 2022 | -33.72% |
| Sep 30, 2022 | 307.21% |
| Jun 30, 2022 | 447.97% |
| Mar 31, 2022 | -126.47% |
| Dec 31, 2021 | -17.13% |
| Sep 30, 2021 | 40.75% |
| Jun 30, 2021 | 28.51% |
| Mar 31, 2021 | 488.26% |
| Dec 31, 2020 | 43.46% |
| Sep 30, 2020 | -14.64% |
| Jun 30, 2020 | -124.91% |
| Mar 31, 2020 | -300.65% |
| Dec 31, 2019 | -4.12% |
| Sep 30, 2019 | -991.42% |
| Jun 30, 2019 | 41.25% |
| Mar 31, 2019 | 188.39% |